Cedric Dos Santos

Company: Genentech

Job title: Director AML/MDS/MM, Translational Medicine

Seminars:

Panel Discussion: Brainstorming Combinations With CART, DDR, Cytokine-Based Therapies & Other Cell Engagers 9:30 am

Discuss potential benefits and risks of combining cell engagers with alternate cancer therapies for personalized treatment strategies How can cell engager combinations be developed to reduce potential relapse while reducing the patient burden of treatment? Can these combinations mitigate T cell exhaustion to improve efficacy across cancer types and reduce patient burden?Read more

day: Conference Day 2

9.00 Expanding Strategic Insights from Early Clinical Trial Development to Improve Successful Development of Cell Engagers 9:00 am

It remains vital to understand early clinical trial design to ensure progression, safety, and efficacy of this highly potent modality. Implement thoughtful patient selection, guided by logical biomarker choices to minimize risk and improve patient outcomes. Explore early trial design, including dosing and close patient monitoring to establish efficacy profiles. Debate different clinical trial design…Read more

day: Workshop B